Summit Global Investments »

Biosante Pharmaceuticals shares owned by Summit Global Investments

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Summit Global Investments from 13F filings

Historical chart of Summit Global Investments investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Summit Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Summit Global Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $773k 14k 55.11